Last reviewed · How we verify
vehicle of OTX-101
vehicle of OTX-101 is a Small molecule drug developed by Sun Pharmaceutical Industries Limited. It is currently in Phase 3 development.
At a glance
| Generic name | vehicle of OTX-101 |
|---|---|
| Sponsor | Sun Pharmaceutical Industries Limited |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca (PHASE3)
- Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca (PHASE2, PHASE3)
- An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- vehicle of OTX-101 CI brief — competitive landscape report
- vehicle of OTX-101 updates RSS · CI watch RSS
- Sun Pharmaceutical Industries Limited portfolio CI
Frequently asked questions about vehicle of OTX-101
What is vehicle of OTX-101?
vehicle of OTX-101 is a Small molecule drug developed by Sun Pharmaceutical Industries Limited.
Who makes vehicle of OTX-101?
vehicle of OTX-101 is developed by Sun Pharmaceutical Industries Limited (see full Sun Pharmaceutical Industries Limited pipeline at /company/sun-pharmaceutical-industries-limited).
What development phase is vehicle of OTX-101 in?
vehicle of OTX-101 is in Phase 3.
Related
- Manufacturer: Sun Pharmaceutical Industries Limited — full pipeline
- Compare: vehicle of OTX-101 vs similar drugs
- Pricing: vehicle of OTX-101 cost, discount & access